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PLINICAL RESEARCH Treatment Standards for Acute Infarction
uration of Ischemia Is a Major
eterminant of Transmurality and Severe
icrovascular Obstruction After Primary Angioplasty
Study Performed With Contrast-Enhanced Magnetic Resonance
iuseppe Tarantini, MD, PHD,* Luisa Cacciavillani, MD,* Francesco Corbetti, MD,†
ngelo Ramondo, MD,* Martina Perazzolo Marra, MD,* Enrico Bacchiega, MD,*
assimo Napodano, MD,* Claudio Bilato, MD, PHD,* Renato Razzolini, MD,*
abino Iliceto, MD, FACC*
adua, Italy
OBJECTIVES This study sought to assess the relationship between duration of ischemia and both
myocardial transmural necrosis (TN) and severe microvascular obstruction (SMO), by
contrast-enhanced magnetic resonance (CE-MR), in patients with acute myocardial infarc-
tion (AMI) treated with angioplasty (PCI), and to estimate the risk of TN and SMO with
the duration of ischemia.
BACKGROUND The impact of ischemic time on myocardial and microvascular injury is not well characterized
in people.
METHODS We performed CE-MR in 77 patients with first AMI, 5  3 days after successful PCI. The
AMI was labeled as transmural if hyperenhancement at CE-MR was extended to 75% of
the thickness in two or more ventricular segments. The SMO was identified as areas of late
hypoenhancement surrounded by hyperenhanced tissue. The relationship between ischemic
time and CE-MR evidence of SMO or TN was evaluated by logistic regression.
RESULTS Thirteen patients were excluded because of preprocedural Thrombolysis In Myocardial
Infarction (TIMI) flow grade 3 of the infarct-related artery. For the remaining 64 patients,
the mean time to treatment was 190 110 min, 45 (65%) patients had TN and 23 (39%) had
SMO. Mean pain to balloon time was 90  40 min, 110  107 min, and 137  97 min in
patients without TN and SMO, with TN but without SMO, or with both TN and SMO,
respectively (p  0.001). Multivariate analysis showed that time delay was significantly
associated both with TN (odds ratio per 30 min, 1.37, p  0.032), and SMO (odds ratio per
30 min, 1.21; p  0.021).
CONCLUSIONS In AMI patients with impaired coronary perfusion undergoing PCI, the risk of TN and SMO
increases with the duration of the ischemic time. (J Am Coll Cardiol 2005;46:1229–35)

















tecent clinical studies have shown that in acute myocardial
nfarction (AMI), delayed reperfusion results in less myo-
ardial salvage and a higher mortality rate, irrespective of the
hosen reperfusion strategy (1,2). In fact, as shown in
xperimental models, the extent of transmurality (3) and the
ntity of the no-reflow (4) are strongly dependent on the
uration of ischemia before reperfusion, with reduced sal-
age of myocardium when reperfusion is accomplished after
wo hours of coronary occlusion. In patients with ST-
egment elevation myocardial infarction, myocardial salvage
rogressively declines as the time between symptoms and
herapy increases (2,5). Moreover, a clear relationship be-
ween every minute in treatment delay and mortality re-
ently has been shown by De Luca et al. (2). Recent clinical
tudies in patients with reperfused AMI have shown a close
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005, accepted June 7, 2005.elation among microvasculature obstruction, myocardial
iability, left ventricular function, and clinical outcome
6–8). However, although explored in experimental studies,
he impact of ischemic time on the extent of myocardial and
icrovascular injury has not been fully clarified in people.
he goals of this study, conducted in patients with AMI
reated with primary angioplasty (PCI), were: 1) to address
he relationship of duration of ischemia with both myocar-
ial transmural necrosis (TN) and severe microvascular
bstruction (SMO) by using contrast-enhanced magnetic
esonance (CE-MR), and 2) to estimate the risk of TN and
MO with the duration of ischemia.
ETHODS
etween March 2003 and March 2004, a total of 77
atients without prior MI were prospectively enrolled in the
tudy. They were admitted to our department within 12 h of
he onset of AMI and underwent successful primary PCI.
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n two or more contiguous leads, or with new left bundle
ranch block, or with anterior ST-segment depression
aused by posterior infarction at the echocardiogram. All
atients received aspirin 250 mg and heparin (70 IU/kg)
ntravenously before the procedure. Primary PCI with stent
as systematically attempted and accomplished with stan-
ard techniques. Intravenous abciximab was administered in
he cardiac catheterization laboratory at discretion of the
nterventional cardiologist. Enzymatic infarct size was cal-
ulated by the peak release of troponin I obtained by
eterminations systematically performed on the admission
nd every 6 h for the subsequent 24 h, and every 12 h for the
ollowing 2 days. All patients underwent CE-MR 5  3
ays after PCI.
ngiographic data analysis. Two different observers eval-
ated all coronary angiograms, first in a blinded fashion,
hen together to reach a consensus regarding Thrombolysis
n Myocardial Infarction (TIMI) flow grade, collateral flow,
nd blush grade, as previously described (9). A successful
ngioplasty was defined as a combination of postprocedural
IMI flow grade 3 and residual restenosis 30%. Time to
reatment was calculated as the interval from the symptom
nset to the first balloon inflation. True ischemic time was
alculated as the time to treatment in patients presenting at
he index angiography (before primary PCI) with TIMI
ow grade 3 of the infarct-related artery.
agnetic resonance data analysis. Patients were exam-
ned in a supine position on a clinical 1.0-T scanner
Harmony, Siemens, Erlangen, Germany) using cardiologic
oftware by Siemens with system MRease SYNGO 2002B.
ll images were acquired using a four-channel phased-array
eceiver coil during repeated breath holds of varying dura-
ion depending on heart rate and patient compliance (12 to
5 s). Images were acquired using a steady-state free-
recession sequence (true FISP) in three short-axis views (at
he level of the mitral valve, papillary muscles, and apex) and
hree long-axis views (two, three, and four chambers).
ontrast-enhanced images were acquired in the same views
0 min after intravenous administration of a gadolinium-
ased contrast agent (gadobenate dimeglumine, Multi-
ance, Bracco, 0.2 mmol/kg of body weight). The images
ere analyzed using a 17-segment model (10) indepen-
ently by two observers blinded to clinical and procedural
haracteristics.
Abbreviations and Acronyms
AMI  acute myocardial infarction
CE-MR  contrast-enhanced magnetic resonance
MBG  myocardial blush grade
PCI  percutaneous coronary intervention
SMO  severe microvascular obstruction
TIMI  Thrombolysis In Myocardial Infarction
TN  transmural necrosisTo evaluate areas of late enhancement and to differentiate
g
cnfarcted from noninfarcted myocardium, a segmented gra-
ient echo inversion recovery turbo FLASH sequence was
sed with the following characteristics: inversion time op-
imized for each patient, 17 to 21 K-space lines acquisition
very 1 or 2 R-R interval (depending on heart frequency),
E 6 ms, flip angle 30°, BW 150 hz/pixel, resolution 134
56, typical voxel size of approximately 1.8  1.3  8 mm
epending on the field of view (300 to 360 mm in relation
o the patient’s size), and slice thickness of 8 mm. Consid-
ring the T1 relaxation times of the tissues on the magnetic
esonance imaging unit (1.0-T) and the wash-in and wash-
ut kinetics of extracellular interstitial contrast agents (11),
he optimized T1 nullifies the signal from normal myocar-
ium in the images acquired 10 min after contrast medium
njection, allowing a clear visualization of the late enhanced
nfarcted areas, characterized, by definition (12), as a signal
ntensity at least 400% higher than the signal from normal
remote) myocardium.
Areas of gadolinium enhancement were assessed by visual
pproach with a scheme based on the spatial extent of
elayed enhancement tissue within each segment as re-
orted by others (13). The AMI was labeled as transmural
f hyperenhancement was extended to 75% of the thick-
ess of at least two contiguous ventricular segments.
We defined SMO (severe microvascular damage in the
nfarct core) as subendocardial areas of late low or absent
ignal surrounded by late enhanced tissue (14,15) in at least
ne ventricular segment.
tatistical analysis. Data are expressed as mean value 
tandard deviation for continuous variables, and as fre-
uency with percentage for categorical variables. Differences
etween means of continuous variables were tested by the
able 1. Patient Characteristics
Characteristics Value
ge (yrs) 60  11.5
en, n (%) 65 (84)
urrent smoker, n (%) 41 (53)
ypertension, n (%) 38 (49)
iabetes mellitus, n (%) 7 (9)
revious angina pectoris, n (%) 19 (25)
revious coronary angioplasty, n (%) 4 (5)
revious coronary bypass, n (%) 0
ocation of myocardial infarction
Anterior n (%) 39 (51)
Inferior, n (%) 35 (46)
ain to balloon time, min 190  111
re TIMI flow grade 3, n (%) 13 (17)
BG 2/3, n (%) 55 (71)
bciximab, n (%) 16 (20)
tent, n (%) 72 (95)
roponin I, g/l 91  90
eft ventricular ejection fraction (%) 59  14
E-MR image of TN, n (%) 50 (65)
E-MR image of SMO, n (%) 25 (32)
ata are presented as mean value  standard deviation or number (%) of patients in
roup.
CE-MR  contrast-enhanced magnetic resonance; MBG  myocardial blush
rade; SMO  severe microvascular obstruction; TIMI  Thrombolysis In Myo-




















































































1231JACC Vol. 46, No. 7, 2005 Tarantini et al.
October 4, 2005:1229–35 Myocardial-Microvascular Injury and Ischemic Timene-way analysis of variance. Frequencies were compared
sing the chi-square or Fisher exact test analysis when the
xpected value of cells was5. A logistic regression analysis
as used to evaluate the relationship between time to
reatment and (patient) CE-MR evidence of TN or SMO
nd to calculate odds ratios (for each 30-min delay) after
djustment for characteristics related to the ischemic time.
he relationships between ischemic time and patient prob-
bility of SMO and/or TN at CE-MR were reported as a
ontinuous function. All MR measurements were per-
ormed independently by two observers (M.P.M. and F.C.)
linded to clinical and procedural characteristics and subse-
uently by one observer (F.C.) one week later. An interob-
erver and intraobserver concordance of 98% and 99%,
espectively, was found in evaluation of TN. In this case,
iscrepancies were resolved by consensus. By contrast, full
greement was reported for SMO. Comparison of propor-
ions was performed using the chi-square test. Data were
nalyzed by SPSS 12 for Windows (SPSS Inc., Chicago,
llinois).
ESULTS
linical and procedural characteristics of the 77 patients
nrolled are summarized in Table 1. The mean time to
reatment was 190  111 min. Thirteen (17%) patients
lready had a TIMI flow grade 3 at the index angiography
efore the primary PCI. Myocardial blush grade (MBG) 2
r 3 was observed in 55 subjects (70%). Collateral circula-
ion (Rentrop 2 or 3) was present only in two patients. Fifty
atients (65%) had CE-MR evidence of TN, and 25 (32%)
f SMO.
able 2. Percentage of MBG 2/3, Transmural Necrosis, and
evere Microvascular Obstruction in Patients According to







atients, n 64 13
ime to treatment, min 190  110 189  110 0.97
BG 0/1, n (%) 20 (31) 2 (15) 0.1
ransmural necrosis,
n (%)
45 (65) 5 (38) 0.036
icrovascular obstruction,
n (%)
23 (39) 2 (15) 0.045
eak of troponin I, g/l 101  96 41  60 0.042
ata are presented as mean value  standard deviation, or number (%) of patients in
roup.
Abbreviations as in Table 1.
Table 3. Ischemic Time and Enzymatic Data
SMO in Patients Without TIMI Flow Grade
TN/SMO
Patients, n (%) 19 (29.7)
Time to treatment, min* 90  40
Peak of troponin I, g/l† 53  50
Data are presented as mean value  standard deviation, o
subgroups: *p  0.001, †p  0.01.
Abbreviations as in Table 1.Table 2 summarizes the presence of MBG 0/1, TN, and
MO in patients with or without TIMI flow grade 3.
espite a similar delay in time to treatment between the two
roups, the percentages of patients with TN and SMO, as
ell as the levels of troponin I release, were significantly
igher in patients with TIMI flow grade 3. A similar
rend, although not yet statistically significant, was observed
or MBG 0/1.
When only patients with TIMI flow grade 3 were
onsidered, pain to balloon time (reasonably the expression
f the ischemic time in these patients) and peak troponin I
evels were positively correlated with the presence of TN
nd SMO. In fact, the pain to balloon time was progres-
ively longer and troponin I release was progressively greater
n patients with both TN and SMO compared with those
ith TN but not SMO, and those with neither TN nor
MO (Table 3). Three typical examples of TN and/or
MO detected by CE-MR are shown in Figure 1. Among
emographic, clinical, and angiographic characteristics of
hese patients (Table 4), the only variables significantly
elated to the ischemic time were abciximab use (abciximab,
36  41 min vs. no abciximab, 205  120 min, p  0.03)
nd MBG 2/3 (MBG 2/3, 160  93 min vs. no MBG 0/1,
33  116 min, p  0.01). By contrast, age was not related
o the ischemic time, even when analyzed as a continuous
ariable (p  0.8).
After adjustment for these confounders, patients with
IMI flow grade 3 showed, for each 30-min delay in
eperfusion, the increase of both TN (odds ratio per 30 min,
.37; 95% confidence interval, 1.03 to 1.8; p  0.032), and
MO (odds ratio per 30 min, 1.21; 95% confidence interval,
.03 to 1.4; p  0.021). Figure 2 illustrates the relation
mong time to reperfusion and (patient) probability of TN
nd/or SMO as continuous functions. Total ischemic time
as closely correlated with CE-MR evidence of TN and
MO. In addition, a close correlation was observed between
he presence of SMO and the evidence of TN at CE-MR
chi-square  6.2, p  0.01), with SMO always detected in
ssociation with TN.
ISCUSSION
n animal models, the association between duration of the
essel occlusion and both TN (3) and no-reflow extent (4)
as been well characterized. To the best of our knowledge,
ur study first shows a similar relationship in people. After
xcluding patients with preprocedural TIMI flow grade 3 of
rding to the CE-MR Evidence of TN and/or
Infarct-Related Artery at Index Angiography
TN/SMO TN/SMO
22 (34.4) 23 (35.9)
177  101 255  145
110  107 137  97
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rom symptom onset to balloon inflation likely represents an
ndicator of total ischemic time. In this population, we
ound a continuous relationship among ischemic time and
robability of TN and SMO, assessed by CE-MR. In fact,
or each 30-min delay in treatment of patients undergoing
igure 1. Typical examples of the different myocardial alterations detect
ercutaneous coronary intervention at an increasing time delay from the
ontrast-enhanced magnetic resonance images obtained at two different sh
Patient A, left column) Male, age 76 years; hypertension, history of sm
vidence of anterior ST-segment elevation myocardial infarct (STEMI); p
cute event, no signs of necrosis are shown at the late contrast-enhanceme
olumn) Male, age 49 years, hypertension, familiarity of coronary artery d
70 min; troponin I peak: 38.6 ng/ml. After six days from acute event, M
nterior wall. (Patient C, right center column) Male, age 78 years, hyper
ime: 240 min; troponin I peak: 199 ng/ml. After eight days from acute eve
egment of the inferior wall. (Patient D, right column) Female, age 73 yea
nd inferior STEMI; pain to balloon time: 310 min; troponin I peak: 258
he anterolateral, anterior, and septal wall. In the same area of the infarct, th
bstruction.
able 4. Patient Characteristics and Ischemic Time
Variables Yes No p Value
ge 70 yrs 163  78 198  118 0.3
ale gender 189  117 198  83 0.8
iabetes 177  99 192  114 0.7
ypertension 203  120 179  102 0.3
urrent smoker 207  133 172  78 0.2
nterior infarction 201  124 98  16 0.5
bciximab 136  41 205  120 0.03
BG 2/3 160  93 233  116 0.01i
ata are presented as mean value  standard deviation.
MBG  myocardial blush grade.uccessful primary PCI, the risk of TN or SMO increases by
7% and 21%, respectively. Although there was also a close
orrelation between presence of SMO and evidence of TN,
t is noteworthy that for any time of reperfusion the
robability of transmurality was higher than that of SMO
Fig. 2). In other words, SMO occurs later than TN,
uggesting that, from a pathophysiologic point of view,
MO lags behind TN. These results are consistent with
hose of a recent experimental animal study, which showed
hat both transmurality (3) and microvascular dysfunction
epend on the duration of ischemia and that the extent of
o reflow is driven by the extent of infarct size (4). In our
tudy, we did not evaluate the infarct size; however, our
esults show that in patients with AMI undergoing success-
ul primary PCI, without preprocedural normal flow of
nfarct-related artery, TN and, more interestingly, SMO are
trongly related to the length of ischemia. Similarly, the
contrast-enhanced magnetic resonance in patients undergoing primary
of the chest pain. Upper, middle, and lower panels respectively show
is levels and in a long-axis two-chamber plane for four different patients.
, dyslipidemia, familiarity of coronary artery disease; electrocardiographic
balloon time: 70 min; troponin I peak: 11.7 ng/ml. After six days from
gnetic resonance image (MRI) (“aborted” infarct). (Patient B, left center
; electrocardiographic evidence of anterior STEMI; pain to balloon time:
hows a nontransmural necrosis in the middle and apical segments of the
n; electrocardiographic evidence of anteroseptal STEMI; pain to balloon
RI shows a transmural necrosis of the entire anterior wall and of the apical
cardiovascular risk factor; electrocardiographic evidence of septal, anterior
l. After seven days from acute event, MRI shows a transmural necrosis of
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MO compared with those with TN but not SMO and
hose with neither TN nor SMO.
Thus, it is not surprising that a longer duration of
schemia corresponds to a more pronounced impairment of
yocardial perfusion (assessed by ST-segment resolution or
yocardial blush) and, as a consequence, to a larger infarct
ize and a worse clinical outcome even when optimal
echanical reperfusion is applied (7,17). In other words,
estoration of TIMI flow grade 3 epicardial flow by PCI
oes not guarantee per se the normalization of myocardial
erfusion (17). Therefore, although primary PCI, in com-
arison with thrombolysis, may guarantee a higher rate of
ecanalization in patients presenting late, it cannot prevent
N and SMO, which are strongly related, even after PCI,
o the duration of occlusion. Interestingly, although infarct
ize is a major determinant of microvascular obstruction for
ny given delay in time to treatment, both experimental and
linical studies suggested that microvascular obstruction per
e is a stronger predictor of worse left ventricular function
nd postinfarct complications compared with infarct size
igure 2. Relationship between ischemic time and in-hospital (patient) pro
ssessed with logistic regression model. The coefficients of both equations
xpressed in number (%); open circles  observed SMO rate expressed i7,18). On the other hand, TN seems to delineate viable and wonviable myocardium and predicts recovery of left ventric-
lar function after MI (16).
We defined SMO as late hypoenhancement within a
yperenhanced area. The presence of persistent hypoen-
ancement within a late hyperenhanced area has been noted
efore (14,15). Recently, Lund et al. (19) reported a high
oncordance between MO on first-pass enhancement MR
mages and SMO on delayed-enhancement MR images
efined as late hypoenhancement (correlation coefficient,
.71). They suggested that the difference could be explained
y extensive microvascular damage resulting in persistent
ypoenhancement even at late imaging. Here our intention
as to report on the severe form of SMO and to focus our
nalysis on severe cases with persistent contrast filling
efects, which recently have been shown to be related to
orse remodeling and outcome (8).
It has been shown that the presence of blood flow in the
nfarct-related artery before PCI is associated with smaller
nzymatic infarct size and better outcome (20). Thus, we
lso analyzed the impact of preprocedural flow on the
rognostic role of time delay, and we found that patients
ty of transmural necrosis (TN) or severe microvascular dysfunction (SMO)
been computed for 30-min intervals. Filled circles  observed TN rate
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Myocardial-Microvascular Injury and Ischemic Time October 4, 2005:1229–35ad a lower rate of TN, SMO, and, not surprisingly, smaller
roponin infarct size than patients without TIMI flow grade
, despite a similar time delay between the two groups
Table 2). Therefore, from a pathophysiologic point of view,
ur data further support the prognostic role of early resto-
ation of the flow as a predictor of successful myocardial
eperfusion and are in agreement with the observations by
thers on the relationships between preprocedural TIMI
ow grade 3 and a higher rate of postprocedural TIMI flow
rade 3, MBG 2 or 3, smaller infarct size, and better
utcome (17,20–22).
The predictive value of preprocedural TIMI flow grade 3
ould argue its independency from the time to treatment;
owever, early drug administration was also shown to be
ssociated with higher rates of vessel patency and aborted
yocardial infarction (23,24), suggesting the importance of
educing the true ischemic time.
The presence of collateral blood flow is an alternative
ource of blood supply to a myocardium jeopardized by
brupt occlusion of the vessel, and it has been shown to
reserve the myocardium in acute phase of MI, favoring
mprovement in left ventricular function after successful
rimary PCI (25). However, coronary angiography, the
ost commonly used technique for studying collateral
irculation, may not be accurate in assessing collateral
irculation because most collateral vessels are too small to be
ngiographically visualized (26). In our study, the limited
umber (n  2) of patients with evident collateral circula-
ion does not allow definitive conclusions.
tudy limitations. This is an observational study; the
atients were enrolled at our institution because of a first
MI and underwent successful primary PCI. Therefore,
his population may not be representative of all AMI
atients treated with primary PCI.
Our study presents some limitations. First, areas and
uantification of transmural extent of necrosis were not
dentified by software, but were assessed visually. Second,
he incomplete coverage of left ventricular myocardium
sing three short-axis and three long-axis slices only may
ave led to missing segments with TN and SMO, therefore
ating patients as falsely negative for TN or SMO. Simi-
arly, mild MO might have been missed because of appli-
ation of the sequence at minute 10.
However, the choice of use of a standardized myocardial
egmentation according to the American Heart Association
10) limits the potential loss of clinically relevant morpho-
ogic information (on a per-patient basis analysis). This
oint is supported by the fact that troponin I release, a
ecognized clinical correlate of infarct size (16), was pro-
ressively and significantly greater in patients with both TN
nd SMO compared with those with TN but not SMO and
hose with neither TN nor SMO (Table 3).
The slope of the relationship between ischemic time and
N or SMO might vary according to the numbers of
entricular segments considered to define the transmural
MI. The design of our study did not allow for infarct Eizing; therefore, no conclusive relationship among ischemic
ime and infarct size and extension of microvascular ob-
truction can be made.
In our study, abciximab use was administered at the
iscretion of the interventional cardiologist during or after
CI. To evaluate the impact of true ischemic time on TN
nd SMO, we restricted our analysis to those patients
ithout an open infarct-related artery at index angiography
nd who underwent successful PCI. Additional studies are
equired to determine whether abciximab use may limit
MO beyond TIMI flow grade 3 (coronary patency) after
CI.
Although our results show that ischemic time, probability
f TN, and SMO are correlated, the small sample size limits
he power and precludes broad generalization into diagnos-
ic terms to predict accurately the patient probability of TN
nd SMO, and needs confirmation in a larger study. Finally,
yocardial infarctions have complex structure with a vary-
ng transmural extent, making a transmural/nontransmural
ivision rarely simply one or the other (27). Because of these
onsiderations, caution should be used in making definitive
nferences from our results.
linical implications. Although primary PCI had been
hown to be superior to thrombolytic therapy (28,29),
everal areas of improvement remain. The potential time
elay remains a major drawback to primary PCI. Indeed,
mong the patients presenting within two hours of the
ymptom onset enrolled in the CAPTIM study, prehospital
hrombolysis resulted in a better outcome compared with
hat for transfer for PCI (30). A critically important goal of
eperfusion is to restore flow of the infarct-related artery as
uickly and as completely as possible, but the ultimate goal
f reperfusion in ST-segment elevation AMI is to reduce
yocardial damage and to improve myocardial perfusion in
he risk area. The results of our study suggest that in
atients with ST-segment elevation AMI undergoing pri-
ary PCI, all efforts should be made to shorten the time
rom symptom onset and reperfusion, because even small
ifferences in time delay result in a significant increase in
N and SMO.
Although normal flow of the infarct-related artery before
CI may affect myocardial salvage and the extent of
icrovascular dysfunction, facilitating reperfusion by phar-
acologic therapy before PCI needs further investigation.
owever, from a pathophysiologic point of view, our study
upports the growing evidence that strategies aimed to
educe the ischemic time should be strongly implemented to
btain early and optimal restoration of anterograde flow and
o reduce the prevalence of transmural necrosis and micro-
ascular dysfunction.
eprint requests and correspondence: Dr. Giuseppe Tarantini,
epartment of Cardiac, Thoracic, and Vascular Sciences, Poli-
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